UCN-01 (7-Hydroxystaurosporine) to Treat Relapsed T-Cell Lymphomas

Stopped IND was withdrawn by CTEP due to low accrual and cost of maintaining the IND.

Conditions

• Lymphoma, Large-Cell, Ki-1
• Lymphoma, T-Cell

Interventions

• DRUG: UCN-01 (7-hydroxystaurosporine)

Sponsor

National Cancer Institute (NCI)